Alexion Antibody Technologies

Develops therapeutic humanized antibodies.

History:

Alexion Antibody Technologies was founded as Prolifaron in 1997 and then acquired by Alexion Pharmaceuticals in 2000.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: subsidiary

Employees:

Regions:
Southern California

Research Focus:
Disease Therapeutics-Research Therapeutics - Development

 

Profiles: BioSpace

 

News:

Keywords: 

Strategic Partnerships: